Biomarin Pharmaceutical Inc (BMRN)
68.01
-0.72
(-1.05%)
USD |
NASDAQ |
Feb 21, 15:50
Biomarin Pharmaceutical Market Cap: 12.97B for Feb. 21, 2025
View 4,000+ Financial Data Types:
Add
Browse
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Pfizer Inc | 149.86B |
Alnylam Pharmaceuticals Inc | 32.29B |
Merck & Co Inc | 225.81B |
Moderna Inc | 13.60B |
Blueprint Medicines Corp | 5.893B |
Market Cap Related Metrics
PE Ratio | 30.91 |
PS Ratio | 4.727 |
PEG Ratio | 0.2061 |
Price to Book Value | 2.293 |
Price to Free Cash Flow | 28.38 |
Price | 68.01 |
Earnings Yield | 3.23% |
PEGY Ratio | 0.2061 |
Operating PE Ratio | 28.45 |
Normalized PE Ratio | 31.52 |